Related Experiment Video
Updated: Sep 24, 2026

Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration
Published on: January 22, 2014
Expression and purification of recombinant Protein L variants in Escherichia coli
Xiaoyong Jiang1, Ruirui Wu2, Kexin Xu1
1Downstream Process Development (DSPD), WuXi Biologics, No.1, 1150 Lan Feng Road, Feng Xian District, Shanghai, 201403, China.
Abstract:
Protein L is a κ light-chain-binding protein, which is widely used as an affinity ligand for antibody purification and characterization. However, manufacturable recombinant Protein L ligands remain insufficiently studied, particularly regarding how domain architecture affects production, processability, and product quality. In the current study, we designed, expressed and purified three recombinant Protein L variants with distinct domain architectures. This allowed the influence of domain architecture on manufacturability, stability, and downstream functionality to be explored. While differences in intermediate purity and recovery were observed among the three different variants, the optimized process allowed highly purified recombinant Protein L to be generated. As a functional validation, one of the purified variants (i.e., rPL02) was immobilized onto a membrane support, which was used to purify a κ light chain-containing single-chain variable fragment (scFv). The Protein L membrane device not only captured the target scFv but also removed the product-related aggregates under the tested conditions. In conclusion, the current work established a practical platform for producing functional recombinant Protein L. Meanwhile, it provided valuable information for future development of manufacturable recombinant Protein L for affinity media.

